This brand name is authorized in United States. It is also authorized in Canada.
The drug BEPREVE contains one active pharmaceutical ingredient (API):
1
|
Bepotastine
UNII
6W18MO1QR3 - BEPOTASTINE BESYLATE
|
|
Bepotastine is a topically active, direct H1-receptor antagonist and an inhibitor of the release of histamine from mast cells. It is indicated for the treatment of itching associated with signs and symptoms of allergic conjunctivitis. |
Below package inserts are available for further reading:
| Document | Type | Information Source | |
|---|---|---|---|
| BEPREVE Ophthalmic solution | MPI, US: SPL/PLR | FDA, National Drug Code (US) |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| CA | Health Products and Food Branch | 02456532 |
| US | FDA, National Drug Code | 24208-629 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.